Related Experiment Video
Updated: Aug 14, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Infective endocarditis in children
1Department of Pediatrics, Yale University School of Medicine, New Haven, CT.
Insights
Infective endocarditis (IE) in children is linked to congenital heart defects, with bacterial causes shifting over time. Treatment strategies vary based on the causative agent and valve status, emphasizing medical management when possible.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Cardiovascular Surgery
Background:
- Infective endocarditis (IE) in children is predominantly associated with congenital structural heart lesions, particularly septal defects.
- The incidence of IE linked to rheumatic heart disease has significantly decreased over the last two decades.
- Nosocomial catheter-associated bacteremia is an emerging risk factor for IE, especially in infants.
Purpose of the Study:
- To review the current landscape of infective endocarditis in pediatric populations.
- To outline the changing etiologies and common causative agents of IE in children.
- To discuss contemporary management strategies and antibiotic regimens for pediatric IE.
Main Methods:
- Review of recent literature and clinical data on pediatric infective endocarditis.
- Analysis of trends in causative microorganisms and associated cardiac conditions.
- Evaluation of current therapeutic approaches, including medical and surgical interventions.
Main Results:
- Congenital heart defects remain the primary predisposing factor for IE in children.
- Streptococci are the most common cause of IE in natural valves, while staphylococci and Gram-negative rods are more frequent in nosocomial infections.
- Medical management is often successful, with surgical intervention reserved for cases of clinical or microbiological failure.
Conclusions:
- The etiology of pediatric IE has evolved, with a decline in rheumatic heart disease and an increase in catheter-associated infections.
- Appropriate antibiotic selection, guided by causative agents and susceptibility, is crucial for successful treatment.
- Further research is needed on effective treatments for IE caused by multidrug-resistant organisms in children.
Abstract:
IE in children is associated primarily with underlying congenital structural heart lesions, predominantly septal defects or complex lesions involving septal defects. During the past 20 years IE associated with rheumatic heart disease has declined to a negligible number. Recently nosocomial catheter-associated bacteremia has been associated with the development of IE, especially in infants. Streptococci are most frequently associated with IE involving natural valves. Although streptococci have also been implicated in cases of IE associated with previous surgery or catheter-related infection, staphylococci, Gram-negative rod species and multiple infecting species are also encountered in this setting. Because infection can often be managed medically, removal of grafts or prosthetic valves is not necessary unless clinical or microbiologic failure occurs. Penicillin with or without an aminoglycoside is the regimen for most community-acquired streptococcal IE. A penicillinase-resistant beta-lactam generally is substituted for penicillin in IE caused by an unknown agent and is used in cases of staphylococcal IE. For IE caused by resistant staphylococci, vancomycin is the alternative agent. Currently there is limited information on the efficacy of alternative agents for treating IE caused by enterococci or staphylococci with multiple antibiotic resistance.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction

